Literature DB >> 9268993

Idiopathic macular hole following vitrectomy: implications for pathogenesis.

W J Lipham1, W E Smiddy.   

Abstract

BACKGROUND AND
OBJECTIVE: Attention to the pathogenesis and clinical features of macular hole formation has increased with the advent of therapy. The purpose of this study is to present three cases that occurred in atypical settings that may have important pathogenic implications. PATIENTS AND METHODS: The authors conducted a retrospective study of three patients who presented with macular holes that developed 10 months to 5.5 years after previous vitrectomy. In each case, the cortical vitreous layer was absent in the region of the macula at the time of operation for the macular hole.
RESULTS: The macular hole was successfully sealed and the visual acuity improved in all patients. All three cases in this report lacked an operculum, occurred long after vitreous removal, and had no evidence of any residual cortical vitreous.
CONCLUSIONS: Macular hole formation in the absence of cortical vitreous suggests the possibility that the etiology of macular holes may involve a spontaneous umbo dehiscence rather than vitreous-induced surface traction. A mechanism involving a cystic degenerative process is proposed as the cause of atypical and typical macular hole formation.

Entities:  

Mesh:

Year:  1997        PMID: 9268993

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers        ISSN: 1082-3069


  14 in total

1.  [Is choroidal thickness of importance in idiopathic macular hole?].

Authors:  K B Schaal; S Pollithy; S Dithmar
Journal:  Ophthalmologe       Date:  2012-04       Impact factor: 1.059

2.  Foveolar choroidal blood flow in idiopathic macular hole.

Authors:  Cengiz Aras; Ozcan Ocakoglu; Nilufer Akova
Journal:  Int Ophthalmol       Date:  2005-09-29       Impact factor: 2.031

3.  The outer choroidoscleral boundary in full-thickness macular holes before and after surgery-a swept-source OCT study.

Authors:  Zofia Michalewska; Janusz Michalewski; Zofia Nawrocka; Karolina Dulczewska-Cichecka; Jerzy Nawrocki
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-02-05       Impact factor: 3.117

4.  Macular hole formation, progression, and surgical repair: case series of serial optical coherence tomography and time lapse morphing video study.

Authors:  Ronald C Gentile; Gennady Landa; Mauricio E Pons; Dean Eliott; Richard B Rosen
Journal:  BMC Ophthalmol       Date:  2010-09-17       Impact factor: 2.209

5.  Macular holes following vitrectomy for rhegmatogenous retinal detachment: epiretinal proliferation and spontaneous closure of macular holes.

Authors:  Akinori Uemura; Noboru Arimura; Keita Yamakiri; Kazuki Fujiwara; Eri Furue; Taiji Sakamoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-04-20       Impact factor: 3.117

6.  Development of full-thickness macular hole despite previous posterior vitreous detachment and vitrectomy for retinal detachment: two cases.

Authors:  H G Sheth; J Bainbridge
Journal:  Eur J Ophthalmol       Date:  2008 Nov-Dec       Impact factor: 2.597

7.  A Case of Bilateral Macular Holes Showing Onset and Spontaneous Closure over Very Short Intervals.

Authors:  Wataru Matsumiya; Shigeru Honda; Hisanori Imai; Sentaro Kusuhara; Yasutomo Tsukahara; Akira Negi
Journal:  Case Rep Ophthalmol       Date:  2010-09-13

8.  Non-Foveal Macular Holes After PPV for Macular Pucker.

Authors:  Mostafa Abdellatif Abo El Enin; Hesham M El-Toukhy; Ahmed Swelam
Journal:  Middle East Afr J Ophthalmol       Date:  2010-07

9.  RAPID MACULAR HOLE FORMATION, SPONTANEOUS CLOSURE, AND REOPENING AFTER PARS PLANA VITRECTOMY FOR MACULA-SPARING RETINAL DETACHMENT.

Authors:  Jayanth Sridhar; Justin H Townsend; Aleksandra V Rachitskaya
Journal:  Retin Cases Brief Rep       Date:  2017 Spring

10.  Development of macular holes after rhegmatogenous retinal detachment repair in Japanese patients.

Authors:  Mamiko Shibata; Toshiyuki Oshitari; Fusae Kajita; Takayuki Baba; Eiju Sato; Shuichi Yamamoto
Journal:  J Ophthalmol       Date:  2012-01-18       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.